Download PDF
Semin Respir Crit Care Med 2012; 33(06): 579-587
DOI: 10.1055/s-0032-1325617
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Airway Hyperresponsiveness: New Insights into the Pathogenesis

Marek Lommatzsch
1   Department of Pneumology, University of Rostock, Rostock, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
09 October 2012 (online)

    Permissions and Reprints

Abstract

Airway hyperresponsiveness (AHR) is the most characteristic clinical feature of asthma. The pathogenesis of AHR in asthma is characterized by a variety of epithelial, microbial, and inflammatory triggers on one hand and abnormalities of effector structures in the airways such as smooth muscle cells, blood vessels, and nerves on the other hand. Obesity is increasingly recognized as an important additional factor in the diagnosis and the pathogenesis of AHR in asthma. It is important to note that structural changes in the asthmatic airway can persist in the absence of inflammation. This may be one reason for the observation that potent new antiinflammatory drugs for the treatment of asthma have only little impact on AHR. New therapeutic strategies are, therefore, needed to modulate structural and functional changes in the airways, especially in patients with treatment-resistant severe asthma.

Keywords

asthma - airway hyperresponsiveness - inflammation - smooth muscle - nerves
 

  • References

  • 1 Lemanske Jr RF, Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol 2010; 125 (2, Suppl 2) S95-S102
    CrossrefPubMedGoogle Scholar
  • 2 Larj MJ, Bleecker ER. Therapeutic responses in asthma and COPD. Corticosteroids. Chest 2004; 126 (2, Suppl) 138S-149S , discussion 159S–161S
    CrossrefPubMedGoogle Scholar
  • 3 Koskela HO, Hyvärinen L, Brannan JD, Chan HK, Anderson SD. Sensitivity and validity of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in asthma. Chest 2003; 124 (4) 1341-1349
    CrossrefPubMedGoogle Scholar
  • 4 Erin EM, Zacharasiewicz AS, Nicholson GC , et al. Rapid effect of inhaled ciclesonide in asthma: a randomized, placebo-controlled study. Chest 2008; 134 (4) 740-745
    CrossrefPubMedGoogle Scholar
  • 5 Busse WW, Lemanske Jr RF. Asthma. N Engl J Med 2001; 344 (5) 350-362
    CrossrefPubMedGoogle Scholar
  • 6 Cockcroft DW, Davis BE. Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol 2006; 118 (3) 551-559 , quiz 560–561
    CrossrefPubMedGoogle Scholar
  • 7 Leckie MJ, ten Brinke A, Khan J , et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356 (9248) 2144-2148
    CrossrefPubMedGoogle Scholar
  • 8 Haldar P, Brightling CE, Hargadon B , et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360 (10) 973-984
    CrossrefPubMedGoogle Scholar
  • 9 Pauwels R, Joos G, Van der Straeten M. Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma. Clin Allergy 1988; 18 (4) 317-321
    PubMedGoogle Scholar
  • 10 Cockcroft DW. Direct challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010; 138 (2, Suppl) 18S-24S
    CrossrefPubMedGoogle Scholar
  • 11 Anderson SD. Indirect challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010; 138 (2, Suppl) 25S-30S
    CrossrefPubMedGoogle Scholar
  • 12 Lommatzsch M, Schloetcke K, Klotz J , et al. Brain-derived neurotrophic factor in platelets and airflow limitation in asthma. Am J Respir Crit Care Med 2005; 171 (2) 115-120
    CrossrefPubMedGoogle Scholar
  • 13 Koskela HO, Hyvärinen L, Brannan JD, Chan HK, Anderson SD. Responsiveness to three bronchial provocation tests in patients with asthma. Chest 2003; 124 (6) 2171-2177
    CrossrefPubMedGoogle Scholar
  • 14 Bakirtas A, Turktas I. Methacholine and adenosine 5′-monophosphate challenges in preschool children with cough-variant and classic asthma. Pediatr Pulmonol 2007; 42 (10) 973-979
    CrossrefPubMedGoogle Scholar
  • 15 Suh DI, Lee JK, Kim CK, Koh YY. Bronchial hyperresponsiveness to methacholine and adenosine 5′-monophosphate, and the presence and degree of atopy in young children with asthma. Clin Exp Allergy 2011; 41 (3) 338-345
    CrossrefPubMedGoogle Scholar
  • 16 Sylvester KP, O'Connor BJ, Farebrother HM, Rafferty GF, Greenough A. Cold air and exercise challenge—influence of minute ventilation. J Asthma 2007; 44 (2) 143-147
    CrossrefPubMedGoogle Scholar
  • 17 Grainge CL, Lau LC, Ward JA , et al. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med 2011; 364 (21) 2006-2015
    CrossrefPubMedGoogle Scholar
  • 18 Gern JE. Barnyard microbes and childhood asthma. N Engl J Med 2011; 364 (8) 769-770
    CrossrefPubMedGoogle Scholar
  • 19 Ege MJ, Mayer M, Normand AC , et al; GABRIELA Transregio 22 Study Group. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 2011; 364 (8) 701-709
    CrossrefPubMedGoogle Scholar
  • 20 Holgate ST. The sentinel role of the airway epithelium in asthma pathogenesis. Immunol Rev 2011; 242 (1) 205-219
    CrossrefPubMedGoogle Scholar
  • 21 Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J Allergy Clin Immunol 2011; 128 (3) 451-462 , quiz 463–464
    CrossrefPubMedGoogle Scholar
  • 22 Nakao A, Sagara H, Setoguchi Y , et al. Expression of Smad7 in bronchial epithelial cells is inversely correlated to basement membrane thickness and airway hyperresponsiveness in patients with asthma. J Allergy Clin Immunol 2002; 110 (6) 873-878
    CrossrefPubMedGoogle Scholar
  • 23 Hahn C, Islamian AP, Renz H, Nockher WA. Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation. J Allergy Clin Immunol 2006; 117 (4) 787-794
    CrossrefPubMedGoogle Scholar
  • 24 Sidhu SS, Yuan S, Innes AL , et al. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci U S A 2010; 107 (32) 14170-14175
    CrossrefPubMedGoogle Scholar
  • 25 Halwani R, Al-Abri J, Beland M , et al. CC and CXC chemokines induce airway smooth muscle proliferation and survival. J Immunol 2011; 186 (7) 4156-4163
    CrossrefPubMedGoogle Scholar
  • 26 Lambrecht BN, Hammad H. The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet 2010; 376 (9743) 835-843
    CrossrefPubMedGoogle Scholar
  • 27 Lambrecht BN, Hammad H. Biology of lung dendritic cells at the origin of asthma. Immunity 2009; 31 (3) 412-424
    CrossrefPubMedGoogle Scholar
  • 28 Lambrecht BN, Hammad H. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat Rev Immunol 2003; 3 (12) 994-1003
    CrossrefPubMedGoogle Scholar
  • 29 van Rijt LS, Vos N, Willart M , et al. Persistent activation of dendritic cells after resolution of allergic airway inflammation breaks tolerance to inhaled allergens in mice. Am J Respir Crit Care Med 2011; 184 (3) 303-311
    CrossrefPubMedGoogle Scholar
  • 30 Bratke K, Lommatzsch M, Julius P , et al. Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge. Thorax 2007; 62 (2) 168-175
    CrossrefPubMedGoogle Scholar
  • 31 Dreschler K, Bratke K, Petermann S , et al. Impact of immunotherapy on blood dendritic cells in patients with Hymenoptera venom allergy. J Allergy Clin Immunol 2011; 127 (2) 487-494 , e1–e3
    CrossrefPubMedGoogle Scholar
  • 32 Lambrecht BN. Lung dendritic cells: targets for therapy in allergic disease. Curr Mol Med 2008; 8 (5) 393-400
    CrossrefPubMedGoogle Scholar
  • 33 Robinson DS. The role of the T cell in asthma. J Allergy Clin Immunol 2010; 126 (6) 1081-1091 , quiz 1092–1093
    CrossrefPubMedGoogle Scholar
  • 34 Lloyd CM, Hawrylowicz CM. Regulatory T cells in asthma. Immunity 2009; 31 (3) 438-449
    CrossrefPubMedGoogle Scholar
  • 35 Hartl D, Koller B, Mehlhorn AT , et al. Quantitative and functional impairment of pulmonary CD4+ CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007; 119 (5) 1258-1266
    CrossrefPubMedGoogle Scholar
  • 36 Akbari O, Faul JL, Hoyte EG , et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med 2006; 354 (11) 1117-1129
    CrossrefPubMedGoogle Scholar
  • 37 Vijayanand P, Seumois G, Pickard C , et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med 2007; 356 (14) 1410-1422
    CrossrefPubMedGoogle Scholar
  • 38 Thomas SY, Chyung YH, Luster AD. Natural killer T cells are not the predominant T cell in asthma and likely modulate, not cause, asthma. J Allergy Clin Immunol 2010; 125 (5) 980-984
    CrossrefPubMedGoogle Scholar
  • 39 Bratke K, Julius P, Virchow JC. Invariant natural killer T cells in obstructive pulmonary diseases. N Engl J Med 2007; 357 (2) 194 , author reply 194–195
    PubMedGoogle Scholar
  • 40 Wenzel S, Holgate ST. The mouse trap: it still yields few answers in asthma. Am J Respir Crit Care Med 2006; 174 (11) 1173-1176 , discussion 1176–1178
    CrossrefPubMedGoogle Scholar
  • 41 Lommatzsch M, Julius P, Kuepper M , et al. The course of allergen-induced leukocyte infiltration in human and experimental asthma. J Allergy Clin Immunol 2006; 118 (1) 91-97
    CrossrefPubMedGoogle Scholar
  • 42 Lommatzsch M, Julius P, Virchow JC. Mice running late: T-cell kinetics in models of asthma. Am J Respir Crit Care Med 2007; 175 (5) 522b-523
    CrossrefPubMedGoogle Scholar
  • 43 Corren J. Cytokine inhibition in severe asthma: current knowledge and future directions. Curr Opin Pulm Med 2011; 17 (1) 29-33
    CrossrefPubMedGoogle Scholar
  • 44 Holgate S, Smith N, Massanari M, Jimenez P. Effects of omalizumab on markers of inflammation in patients with allergic asthma. Allergy 2009; 64 (12) 1728-1736
    CrossrefPubMedGoogle Scholar
  • 45 Holgate S, Buhl R, Bousquet J, Smith N, Panahloo Z, Jimenez P. The use of omalizumab in the treatment of severe allergic asthma: a clinical experience update. Respir Med 2009; 103 (8) 1098-1113
    CrossrefPubMedGoogle Scholar
  • 46 Busse WW, Morgan WJ, Gergen PJ , et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011; 364 (11) 1005-1015
    CrossrefPubMedGoogle Scholar
  • 47 Nair P, Pizzichini MM, Kjarsgaard M , et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360 (10) 985-993
    CrossrefPubMedGoogle Scholar
  • 48 Tomkinson A, Tepper J, Morton M , et al. Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma. Allergy 2010; 65 (1) 69-77
    CrossrefPubMedGoogle Scholar
  • 49 Corren J, Lemanske RF, Hanania NA , et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011; 365 (12) 1088-1098
    CrossrefPubMedGoogle Scholar
  • 50 Dougherty RH, Sidhu SS, Raman K , et al. Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. J Allergy Clin Immunol 2010; 125 (5) 1046-1053 , e8
    CrossrefPubMedGoogle Scholar
  • 51 Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 2006; 117 (6) 1277-1284
    CrossrefPubMedGoogle Scholar
  • 52 Ito A, Hagiyama M, Oonuma J. Nerve-mast cell and smooth muscle-mast cell interaction mediated by cell adhesion molecule-1, CADM1. J Smooth Muscle Res 2008; 44 (2) 83-93
    CrossrefPubMedGoogle Scholar
  • 53 Brightling CE, Bradding P. The re-emergence of the mast cell as a pivotal cell in asthma pathogenesis. Curr Allergy Asthma Rep 2005; 5 (2) 130-135
    CrossrefPubMedGoogle Scholar
  • 54 Siddiqui S, Mistry V, Doe C , et al. Airway hyperresponsiveness is dissociated from airway wall structural remodeling. J Allergy Clin Immunol 2008; 122 (2) 335-341 , 341, e1–e3
    CrossrefPubMedGoogle Scholar
  • 55 Graff-Lonnevig V, Hedlin G. The effect of ketotifen on bronchial hyperreactivity in childhood asthma. J Allergy Clin Immunol 1985; 76 (1) 59-63
    CrossrefPubMedGoogle Scholar
  • 56 Holgate ST, Noonan M, Chanez P , et al. Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial. Eur Respir J 2011; 37 (6) 1352-1359
    CrossrefPubMedGoogle Scholar
  • 57 Bush A, Zar HJ. WHO universal definition of severe asthma. Curr Opin Allergy Clin Immunol 2011; 11 (2) 115-121
    CrossrefPubMedGoogle Scholar
  • 58 Pascual RM, Peters SP. The irreversible component of persistent asthma. J Allergy Clin Immunol 2009; 124 (5) 883-890 , quiz 891–892
    CrossrefPubMedGoogle Scholar
  • 59 Proskocil BJ, Fryer AD. Beta2-agonist and anticholinergic drugs in the treatment of lung disease. Proc Am Thorac Soc 2005; 2 (4) 305-310 , discussion 311–312
    CrossrefPubMedGoogle Scholar
  • 60 Canning BJ, Fischer A. Neural regulation of airway smooth muscle tone. Respir Physiol 2001; 125 (1-2) 113-127
    CrossrefPubMedGoogle Scholar
  • 61 Felder CC. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J 1995; 9 (8) 619-625
    PubMedGoogle Scholar
  • 62 Kummer W, Lips KS, Pfeil U. The epithelial cholinergic system of the airways. Histochem Cell Biol 2008; 130 (2) 219-234
    CrossrefPubMedGoogle Scholar
  • 63 Barnes PJ. Overview of neural mechanisms in asthma. Pulm Pharmacol 1995; 8 (4-5) 151-159
    CrossrefPubMedGoogle Scholar
  • 64 Lommatzsch M, Virchow JC. The neural underpinnings of asthma. J Allergy Clin Immunol 2007; 119 (1) 254-255 , author reply 255
    CrossrefPubMedGoogle Scholar
  • 65 Undem BJ, Carr MJ. The role of nerves in asthma. Curr Allergy Asthma Rep 2002; 2 (2) 159-165
    CrossrefPubMedGoogle Scholar
  • 66 Lommatzsch M, Braun A, Renz H. Neurotrophins in allergic airway dysfunction: what the mouse model is teaching us. Ann N Y Acad Sci 2003; 992: 241-249
    CrossrefPubMedGoogle Scholar
  • 67 Verhein KC, Fryer AD, Jacoby DB. Neural control of airway inflammation. Curr Allergy Asthma Rep 2009; 9 (6) 484-490
    CrossrefPubMedGoogle Scholar
  • 68 Fryer AD, Stein LH, Nie Z , et al. Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction. J Clin Invest 2006; 116 (1) 228-236
    PubMedGoogle Scholar
  • 69 Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677-736
    CrossrefPubMedGoogle Scholar
  • 70 Prakash Y, Thompson MA, Meuchel L , et al. Neurotrophins in lung health and disease. Expert Rev Respir Med 2010; 4 (3) 395-411
    CrossrefPubMedGoogle Scholar
  • 71 Lommatzsch M, Zingler D, Schuhbaeck K , et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005; 26 (1) 115-123
    CrossrefPubMedGoogle Scholar
  • 72 Fujimura H, Altar CA, Chen R , et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002; 87 (4) 728-734
    PubMedGoogle Scholar
  • 73 Braun A, Lommatzsch M, Mannsfeldt A , et al. Cellular sources of enhanced brain-derived neurotrophic factor production in a mouse model of allergic inflammation. Am J Respir Cell Mol Biol 1999; 21 (4) 537-546
    CrossrefPubMedGoogle Scholar
  • 74 Braun A, Lommatzsch M, Neuhaus-Steinmetz U , et al. Brain-derived neurotrophic factor (BDNF) contributes to neuronal dysfunction in a model of allergic airway inflammation. Br J Pharmacol 2004; 141 (3) 431-440
    CrossrefPubMedGoogle Scholar
  • 75 Bennedich Kahn L, Gustafsson LE, Olgart Höglund C. Brain-derived neurotrophic factor enhances histamine-induced airway responses and changes levels of exhaled nitric oxide in guinea pigs in vivo. Eur J Pharmacol 2008; 595 (1-3) 78-83
    CrossrefPubMedGoogle Scholar
  • 76 Prakash YS, Thompson MA, Pabelick CM. Brain-derived neurotrophic factor in TNF-alpha modulation of Ca2+ in human airway smooth muscle. Am J Respir Cell Mol Biol 2009; 41 (5) 603-611
    CrossrefPubMedGoogle Scholar
  • 77 Aravamudan B, Thompson M, Pabelick C, Prakash YS. Brain derived neurotrophic factor induces proliferation of human airway smooth muscle cells. J Cell Mol Med 2012; 16 (4) 812-823
    CrossrefPubMedGoogle Scholar
  • 78 Meuchel LW, Stewart A, Smelter DF , et al. Neurokinin-neurotrophin interactions in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2011; 301 (1) L91-L98
    CrossrefPubMedGoogle Scholar
  • 79 Virchow JC, Julius P, Lommatzsch M, Luttmann W, Renz H, Braun A. Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. Am J Respir Crit Care Med 1998; 158 (6) 2002-2005
    CrossrefPubMedGoogle Scholar
  • 80 Kornerup KN, Page CP. The role of platelets in the pathophysiology of asthma. Platelets 2007; 18 (5) 319-328
    CrossrefPubMedGoogle Scholar
  • 81 Pitchford SC, Momi S, Baglioni S , et al. Allergen induces the migration of platelets to lung tissue in allergic asthma. Am J Respir Crit Care Med 2008; 177 (6) 604-612
    CrossrefPubMedGoogle Scholar
  • 82 Lommatzsch M, Lindner Y, Edner A, Bratke K, Kuepper M, Virchow JC. Adverse effects of salmeterol in asthma: a neuronal perspective. Thorax 2009; 64 (9) 763-769
    CrossrefPubMedGoogle Scholar
  • 83 Cazorla M, Prémont J, Mann A, Girard N, Kellendonk C, Rognan D. Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice. J Clin Invest 2011; 121 (5) 1846-1857
    CrossrefPubMedGoogle Scholar
  • 84 Eibl JK, Chapelsky SA, Ross GM. Multipotent neurotrophin antagonist targets brain-derived neurotrophic factor and nerve growth factor. J Pharmacol Exp Ther 2010; 332 (2) 446-454
    CrossrefPubMedGoogle Scholar
  • 85 Stoll P, Plessow A, Bratke K, Virchow JC, Lommatzsch M. Differential effect of clopidogrel and aspirin on the release of BDNF from platelets. J Neuroimmunol 2011; 238 (1-2) 104-106
    CrossrefPubMedGoogle Scholar
  • 86 Ramalho R, Soares R, Couto N, Moreira A. Tachykinin receptors antagonism for asthma: a systematic review. BMC Pulm Med 2011; 11: 41
    CrossrefPubMedGoogle Scholar
  • 87 Caceres AI, Brackmann M, Elia MD , et al. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc Natl Acad Sci U S A 2009; 106 (22) 9099-9104
    PubMedGoogle Scholar
  • 88 Grace MS, Belvisi MG. TRPA1 receptors in cough. Pulm Pharmacol Ther 2011; 24 (3) 286-288
    CrossrefPubMedGoogle Scholar
  • 89 Bara I, Ozier A, Tunon de Lara JM, Marthan R, Berger P. Pathophysiology of bronchial smooth muscle remodelling in asthma. Eur Respir J 2010; 36 (5) 1174-1184
    CrossrefPubMedGoogle Scholar
  • 90 Dekkers BG, Maarsingh H, Meurs H, Gosens R. Airway structural components drive airway smooth muscle remodeling in asthma. Proc Am Thorac Soc 2009; 6 (8) 683-692
    CrossrefPubMedGoogle Scholar
  • 91 An SS, Bai TR, Bates JH , et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J 2007; 29 (5) 834-860
    CrossrefPubMedGoogle Scholar
  • 92 Oliver MN, Fabry B, Marinkovic A, Mijailovich SM, Butler JP, Fredberg JJ. Airway hyperresponsiveness, remodeling, and smooth muscle mass: right answer, wrong reason?. Am J Respir Cell Mol Biol 2007; 37 (3) 264-272
    CrossrefPubMedGoogle Scholar
  • 93 James AL, Bai TR, Mauad T , et al. Airway smooth muscle thickness in asthma is related to severity but not duration of asthma. Eur Respir J 2009; 34 (5) 1040-1045
    CrossrefPubMedGoogle Scholar
  • 94 Araujo BB, Dolhnikoff M, Silva LF , et al. Extracellular matrix components and regulators in the airway smooth muscle in asthma. Eur Respir J 2008; 32 (1) 61-69
    CrossrefPubMedGoogle Scholar
  • 95 Woodruff PG, Dolganov GM, Ferrando RE , et al. Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med 2004; 169 (9) 1001-1006
    CrossrefPubMedGoogle Scholar
  • 96 Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003; 167 (10) 1360-1368
    CrossrefPubMedGoogle Scholar
  • 97 Ma X, Cheng Z, Kong H , et al. Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. Am J Physiol Lung Cell Mol Physiol 2002; 283 (6) L1181-L1189
    PubMedGoogle Scholar
  • 98 Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346 (22) 1699-1705
    CrossrefPubMedGoogle Scholar
  • 99 Brightling CE, Ammit AJ, Kaur D , et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 2005; 171 (10) 1103-1108
    CrossrefPubMedGoogle Scholar
  • 100 Gosens R, Roscioni SS, Dekkers BG , et al. Pharmacology of airway smooth muscle proliferation. Eur J Pharmacol 2008; 585 (2-3) 385-397
    CrossrefPubMedGoogle Scholar
  • 101 Gosens R, Zaagsma J, Grootte Bromhaar M, Nelemans A, Meurs H. Acetylcholine: a novel regulator of airway smooth muscle remodelling?. Eur J Pharmacol 2004; 500 (1-3) 193-201
    CrossrefPubMedGoogle Scholar
  • 102 Durrani SR, Viswanathan RK, Busse WW. What effect does asthma treatment have on airway remodeling? Current perspectives. J Allergy Clin Immunol 2011; 128 (3) 439-448 , quiz 449–450
    CrossrefPubMedGoogle Scholar
  • 103 Peters SP, Kunselman SJ, Icitovic N , et al; National Heart, Lung, and Blood Institute Asthma Clinical Research Network. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363 (18) 1715-1726
    CrossrefPubMedGoogle Scholar
  • 104 Cox G, Thomson NC, Rubin AS , et al; AIR Trial Study Group. Asthma control during the year after bronchial thermoplasty. N Engl J Med 2007; 356 (13) 1327-1337
    CrossrefPubMedGoogle Scholar
  • 105 Castro M, Rubin AS, Laviolette M , et al; AIR2 Trial Study Group. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 2010; 181 (2) 116-124
    CrossrefPubMedGoogle Scholar
  • 106 Thomson NC, Rubin AS, Niven RM , et al; AIR Trial Study Group. Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial. BMC Pulm Med 2011; 11: 8
    CrossrefPubMedGoogle Scholar
  • 107 Corren J. Small airways disease in asthma. Curr Allergy Asthma Rep 2008; 8 (6) 533-539
    CrossrefPubMedGoogle Scholar
  • 108 Salerno FG, Barbaro MP, Toungoussova O, Carpagnano E, Guido P, Spanevello A. The extracellular matrix of the lung and airway responsiveness in asthma. Monaldi Arch Chest Dis 2009; 71 (1) 27-30
    PubMedGoogle Scholar
  • 109 Pini L, Hamid Q, Shannon J , et al. Differences in proteoglycan deposition in the airways of moderate and severe asthmatics. Eur Respir J 2007; 29 (1) 71-77
    PubMedGoogle Scholar
  • 110 An SS, Fredberg JJ. Biophysical basis for airway hyperresponsiveness. Can J Physiol Pharmacol 2007; 85 (7) 700-714
    CrossrefPubMedGoogle Scholar
  • 111 Park HS, Kim SY, Kim SR, Lee YC. Targeting abnormal airway vascularity as a therapeutical strategy in asthma. Respirology 2010; 15 (3) 459-471
    CrossrefPubMedGoogle Scholar
  • 112 Detoraki A, Granata F, Staibano S, Rossi FW, Marone G, Genovese A. Angiogenesis and lymphangiogenesis in bronchial asthma. Allergy 2010; 65 (8) 946-958
    CrossrefPubMedGoogle Scholar
  • 113 Zanini A, Chetta A, Imperatori AS, Spanevello A, Olivieri D. The role of the bronchial microvasculature in the airway remodelling in asthma and COPD. Respir Res 2010; 11: 132
    CrossrefPubMedGoogle Scholar
  • 114 Finucane MM, Stevens GA, Cowan MJ , et al; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet 2011; 377 (9765) 557-567
    CrossrefPubMedGoogle Scholar
  • 115 Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008; 32 (9) 1431-1437
    CrossrefPubMedGoogle Scholar
  • 116 Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol 2008; 121 (5) 1087-1093 , quiz 1094–1095
    CrossrefPubMedGoogle Scholar
  • 117 Shore SA, Johnston RA. Obesity and asthma. Pharmacol Ther 2006; 110 (1) 83-102
    CrossrefPubMedGoogle Scholar
  • 118 Ding DJ, Martin JG, Macklem PT. Effects of lung volume on maximal methacholine-induced bronchoconstriction in normal humans. J Appl Physiol 1987; 62 (3) 1324-1330
    PubMedGoogle Scholar
  • 119 Boulet LP, Turcotte H, Boulet G, Simard B, Robichaud P. Deep inspiration avoidance and airway response to methacholine: influence of body mass index. Can Respir J 2005; 12 (7) 371-376
    PubMedGoogle Scholar
  • 120 Skloot G, Togias A. Bronchodilation and bronchoprotection by deep inspiration and their relationship to bronchial hyperresponsiveness. Clin Rev Allergy Immunol 2003; 24 (1) 55-72
    CrossrefPubMedGoogle Scholar
  • 121 McCallister JW, Parsons JP, Mastronarde JG. The relationship between gastroesophageal reflux and asthma: an update. Ther Adv Respir Dis 2011; 5 (2) 143-150
    CrossrefPubMedGoogle Scholar
  • 122 Thomsen SF, Duffy DL, Kyvik KO, Skytthe A, Backer V. Risk of asthma in adult twins with type 2 diabetes and increased body mass index. Allergy 2011; 66 (4) 562-568
    CrossrefPubMedGoogle Scholar
  • 123 Lafond C, Sériès F, Lemière C. Impact of CPAP on asthmatic patients with obstructive sleep apnoea. Eur Respir J 2007; 29 (2) 307-311
    PubMedGoogle Scholar
  • 124 Torchio R, Gobbi A, Gulotta C , et al. Mechanical effects of obesity on airway responsiveness in otherwise healthy humans. J Appl Physiol 2009; 107 (2) 408-416
    CrossrefPubMedGoogle Scholar
  • 125 Lommatzsch M, Julius P, Virchow JC. Tiotropium step-up therapy in asthma. N Engl J Med 2011; 364 (6) 578 , author reply 578–579
    CrossrefPubMedGoogle Scholar